scholarly journals MO01.38 Registrational Dataset from the Phase 1/2 ARROW Trial of Pralsetinib (BLU-667) in Patients with Advanced RET Fusion+ Non-Small-Cell Lung Cancer (NSCLC)

2021 ◽  
Vol 16 (1) ◽  
pp. S31-S32
Author(s):  
J.F. Gainor ◽  
G. Curigliano ◽  
D.-W. Kim ◽  
D.H. Lee ◽  
B. Besse ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Phase 1 ◽  
Small Cell ◽  
Small Cell Lung

scholarly journals Pembrolizumab and platinum-based chemotherapy as first-line therapy for advanced non–small-cell lung cancer: Phase 1 cohorts from the KEYNOTE-021 study

Lung Cancer ◽  
2018 ◽  
Vol 125 ◽  
pp. 273-281 ◽  
Author(s):  
Shirish M. Gadgeel ◽  
James P. Stevenson ◽  
Corey J. Langer ◽  
Leena Gandhi ◽  
Hossein Borghaei ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Phase 1 ◽  
Small Cell ◽  
Small Cell Lung ◽  
First Line ◽  
First Line Therapy ◽  
Line Therapy ◽  
Platinum Based Chemotherapy

scholarly journals 631. Phase 1/2 Trial of Autologous Tumor Mixed with an Allogeneic GVAX® Immunotherapy in Advanced Stage Non-Small Cell Lung Cancer

2006 ◽  
Vol 13 ◽  
pp. S243
Author(s):  
John Nemunaitis ◽  
Thierry Jahan ◽  
Helen Ross ◽  
Daniel Sterman ◽  
Donald Richards ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Phase 1 ◽  
Small Cell ◽  
Autologous Tumor ◽  
Advanced Stage ◽  
Small Cell Lung

scholarly journals Phase 1 Study of Cabozantinib in Japanese Patients With Expansion Cohorts in Non–Small-Cell Lung Cancer

2019 ◽  
Vol 20 (3) ◽  
pp. e317-e328 ◽  
Author(s):  
Hiroshi Nokihara ◽  
Makoto Nishio ◽  
Noboru Yamamoto ◽  
Yutaka Fujiwara ◽  
Hidehito Horinouchi ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Phase 1 ◽  
Japanese Patients ◽  
Small Cell ◽  
Small Cell Lung ◽  
Phase 1 Study
Sign in / Sign up

Export Citation Format

Share Document